Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • High-Growth Indian Pharma Mutual Funds
    • Equity mutual funds’ average AUM rises 17% in FY26; flexi cap funds lead growth: Abakkus MF
    • Multi-asset fund-of-funds: Active option suits alpha, risk control seekers | Personal Finance
    • Nippon India Mutual Fund Starts Investor Awareness Campaign To Increase Retail Participation | Savings and Investments News
    • XRP News: GraniteShares Just Delayed Its 3x XRP ETFs to May 7
    • Exclusive: UK’s Aviva Investors bought $108m of Israeli government bonds in January sale
    • Montaka Global Investments’ Q1 2026 Investor Letter
    • How AT1 Bonds Could Shape New UBS Banking Regulations in
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»SIP»This mutual fund has turned a ₹10,000 monthly SIP into over ₹1 crore in 12 years
    SIP

    This mutual fund has turned a ₹10,000 monthly SIP into over ₹1 crore in 12 years

    August 13, 2025


    A ₹10,000 monthly systematic investment plan (SIP) in Kotak Contra Fund since its launch in July 2013 would have grown to ₹1.34 crore by June 2025, based on fund house data. Over the same period, the scheme has also outperformed its benchmark, the Nifty 500 TRI, over three-year, five-year, and since-inception timeframes.

    Its corpus recently crossed ₹4,500 crore in assets under management (AUM).

    A lump sum investment of ₹10,000 at inception would have grown to ₹74,825.7 as of July 25, 2025, representing over seven times the initial value. Since inception, the fund has delivered an annualised return of 17.36%.

    On a rolling returns basis, it has generated positive returns in all five-, seven-, and ten-year periods in its history.

    Contra funds follow an investment approach that runs counter to prevailing market sentiment, seeking undervalued companies or sectors currently out of favour but with potential for recovery. The Kotak Contra Fund applies this strategy with a value bias and a strong fundamental overlay, targeting businesses with visible earnings potential or scope for improvement in fundamentals where valuations are attractive relative to historical levels.

    The scheme is managed by Shibani Sircar Kurian and has a Sharpe ratio of 1.36, indicating the returns generated in relation to the risk taken. While market cap allocation is flexible, the portfolio at the end of June 2025 held around 60% in large-cap stocks, and a little over 18.5% each in mid- and small-cap stocks.

    As of June 2025, sector positioning showed overweight exposure to financial services, healthcare, consumer discretionary, and technology, with underweight positions in metals and media.

    Market analysts caution that contrarian strategies can diverge from prevailing trends, leading to short-term underperformance. Investors typically need to align such strategies with their investment horizon and risk tolerance.

    ALSO READ | This mutual fund has given over 13 times returns on a lump sum in 20 years

    First Published: Aug 13, 2025 3:00 PM IST



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Rs 10,000 SIP amid market volatility: Should you continue investing or quit & reduce risk?

    April 21, 2026

    SIP stoppage ratio crosses 100% as market volatility hits investors

    April 18, 2026

    Lifestraw’s lightest water filter ever: Sip Essential survival straw

    April 16, 2026
    Leave A Reply Cancel Reply

    Top Posts

    The Shifting Landscape of Art Investment and the Rise of Accessibility: The London Art Exchange

    September 11, 2023

    Charlie Cobham: The Art Broker Extraordinaire Maximizing Returns for High Net Worth Clients

    February 12, 2024

    High-Growth Indian Pharma Mutual Funds

    April 24, 2026

    The Unyielding Resilience of the Art Market: A Historical and Contemporary Perspective

    November 19, 2023
    Don't Miss
    Mutual Funds

    High-Growth Indian Pharma Mutual Funds

    April 24, 2026

    What are pharma mutual funds?These funds invest in pharmaceutical and healthcare companies. They mainly include…

    Equity mutual funds’ average AUM rises 17% in FY26; flexi cap funds lead growth: Abakkus MF

    April 23, 2026

    Multi-asset fund-of-funds: Active option suits alpha, risk control seekers | Personal Finance

    April 23, 2026

    Nippon India Mutual Fund Starts Investor Awareness Campaign To Increase Retail Participation | Savings and Investments News

    April 23, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    The Weekly Sip: Keurig Dr Pepper serves Shirley Temple 7UP | Constellation taps CPG veteran as executive VP

    October 10, 2024

    Dubai Investments names new Chief Financial Officer

    March 27, 2026

    How to create a second income from UK property without purchasing a buy-to-let

    July 17, 2025
    Our Picks

    High-Growth Indian Pharma Mutual Funds

    April 24, 2026

    Equity mutual funds’ average AUM rises 17% in FY26; flexi cap funds lead growth: Abakkus MF

    April 23, 2026

    Multi-asset fund-of-funds: Active option suits alpha, risk control seekers | Personal Finance

    April 23, 2026
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    💵 Libra responds after Flamengo takes legal action and ‘freezes’ funds

    September 26, 2025

    ₹50 lakh retirement corpus: How to invest in SCSS, mutual funds, equities and other assets — CA offers tips

    April 16, 2026
    © 2026 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.